Literature DB >> 2451548

Gamma gene promoter and enhancer structure in Seattle variant of hereditary persistence of fetal hemoglobin.

R E Gelinas1, M Rixon, W Magis, G Stamatoyannopoulos.   

Abstract

A variant of hereditary persistence of fetal hemoglobin (HPFH), first described in a patient from Seattle, was studied by structural analysis of the gamma-globin genes. A family study suggested that the determinant for this form of HPFH, in which the HbF contains both G gamma- and A gamma-globin chains, segregated with the beta S gene. No deletions or other abnormalities were detected in the fetal to adult globin gene region by genomic mapping studies. All four gamma-globin genes were isolated from a cosmid library, and allelic pairs of gamma-globin genes were distinguished by linkage to either the beta S- or beta A-globin gene. Nucleotide sequence analysis of the four gamma-globin gene promoters revealed a total of three discrepancies compared with a reference sequence, but these were judged unlikely to be the underlying determinants. Sequence analysis of the enhancer region located 3' to the A gamma-globin gene from the putative HPFH chromosome revealed three base substitutions, whereas this region was normal in the A gamma-globin gene linked to the beta A gene. These data raise the possibility that an alteration of enhancer function rather than promoter function could be the basis for this condition.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2451548

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  2 in total

1.  Nucleotide variations in the 3' A gamma enhancer region are linked to beta-gene cluster haplotypes and are unrelated to fetal hemoglobin expression.

Authors:  A Ragusa; M Lombardo; E Bouhassira; C Beldjord; T Lombardo; R L Nagel; D Labie; R Krishnamoorthy
Journal:  Am J Hum Genet       Date:  1989-07       Impact factor: 11.025

2.  Role of gene order in developmental control of human gamma- and beta-globin gene expression.

Authors:  K R Peterson; G Stamatoyannopoulos
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.